The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...
From life-altering genetic conditions to promising new treatments, here's what you need to know about 7 inherited diseases ...
Biogen has entered a collaboration with Stoke Therapeutics to develop and commercialise zorevunersen to treat Dravet syndrome ...
Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...
The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...
The primary primary cancer – which had already spread throughout her skeleton and also to her brain – was later revealed to ...
Sciencephile the AI on MSN6h
Can We Reprogram Our DNA? The Future of GeneticsThe cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise ...
The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...
Researchers have introduced genetic material into plants via their roots, opening a potential pathway for rapid crop improvement.
15h
WCIV Charleston on MSNGene therapy among cutting-edge treatments at MUSC's new sickle cell center in CharlestonThe Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results